PPACA Case Summary

After the implementation of PPACA, the pharmaceutical companies have restructured their infrastructure to accommodate the methodology of the Act. With the demanding healthcare market and new regulations, unreformed practices can result in penalties and taxes. The steps required to financially survive the requirements are yet to be seen. Evidence shows that various companies are looking to broaden their scope to retain financial earning, by selecting the best possible strategic sources to minimize the liabilities of outdated patents, cost reduction of medications, marketing, and the associated cost for FDA approval. The industry will need to require ways to increase revenue with the least resources used. Such actions will require lawful practices to eliminate unwanted judiciary actions. Utilizing globalization standards …show more content…
However, this might cause the doctors, and companies who have purchased the rights to develop these drugs, to question the sudden increase. It will take a unique balance to allow affordability for the patient, less paperwork for the physician, and still be profitable. Unfortunately, the current strategies used has resulted in investigation by the congressional committees and spurred the creation of a task force to research the details on drug pricing. Especially since evidence indicates that there has been a price increase of nearly fifty percent in the market over the last three years.
The PPACA was implemented for several reasons, but the most pressing was to provide affordable healthcare. The pharmaceutical industry in the past was not subject to harsh consequences for their process of capitalism. The industry was only governed by monetary gain and interest. Moving forward, their interests will need to focus on collaboration across specialties, in order to compensate for their ongoing loss of